In anticipation of its presentation at the 43rd Annual J.P. Morgan Healthcare Conference, Moderna, Inc. (MRNA) has reported achieving betwee...
Showing posts with label Moderna Aims To Reduce 2025 Cash Costs By $1 Billion; FY25 Revenues Of $1.5 Bln To $2.5 Bln. Show all posts
Showing posts with label Moderna Aims To Reduce 2025 Cash Costs By $1 Billion; FY25 Revenues Of $1.5 Bln To $2.5 Bln. Show all posts
Monday, January 13, 2025
Posts
Posts